Predicting deep venous thrombosis and pulmonary embolism in community patients with superficial venous thrombosis: a model development study
van Royen FS., van Smeden M., van Doorn S., Souverein P., van Amsterdam WAC., Rutten FH., Sheppard JP., Geersing GJ.
Background In general practice, superficial venous thrombosis (SVT) is considered a benign condition that does not require anticoagulant treatment. However, a small but not insignificant subgroup of patients will develop serious thrombotic complications, such as deep venous thrombosis (DVT) and/or pulmonary embolism (PE). Tailored anticoagulant treatment in high-risk patients might prevent these complications, yet tools for clinical decision-making are currently lacking. Objectives To develop a multivariable prediction model to identify specific SVT subgroups at higher or lower risk of developing DVT/PE to aid clinical decision-making. Methods Data from general practices in the longitudinal routine care UK Clinical Practice Research Datalink Aurum database were used in this study, covering the period from 2000 to 2021. A multivariable prediction model was developed for adult SVT patients to predict the outcome of DVT and/or PE within 90 days after the first consultation for SVT. Prespecified predictors were biological sex, age, (history of) cancer, history of DVT/PE, and absence of varicose veins. The model’s performance was evaluated using bootstrapping and internal-external cross-validation. Results Of all identified patients with SVT ( N = 293 166; median age, 61 years [IQR, 46-73]; 33% male), 10 301 (3.5%) developed DVT or PE within 90 days. The risk was highest in the first days after the SVT consultation: 51% of DVTs/PEs were diagnosed within 1 week, and 77% within 30 days. The C-statistic of the model was 0.66 (95% CI, 0.66-0.67), and the model showed good calibration (intercept = 0.04, slope = 1.01). High-risk patients with a predicted risk of ≥5% (9.7% of the total population) had a history of DVT/PE or were male with (a history of) cancer. Conclusion In community SVT patients, the average risk of DVT/PE development within 90 days of follow-up is 3.5%. This simple prediction model showed good performance in predicting the short-term risk of DVT/PE and could be used to rule out thrombotic complications in this setting, but also to identify a subgroup of patients at higher risk in whom further diagnostic testing for concomitant DVT/PE and/or short-term preventive anticoagulant treatment should be considered to prevent clot progression.